Syndax Pharmaceuticals (SNDX) Interest & Investment Income (2016 - 2017)
Historic Interest & Investment Income for Syndax Pharmaceuticals (SNDX) over the last 3 years, with Q4 2017 value amounting to $462000.0.
- Syndax Pharmaceuticals' Interest & Investment Income rose 7238.81% to $462000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $1.4 million, marking a year-over-year increase of 4874.48%. This contributed to the annual value of $26.1 million for FY2024, which is 2328.12% up from last year.
- Syndax Pharmaceuticals' Interest & Investment Income amounted to $462000.0 in Q4 2017, which was up 7238.81% from $411000.0 recorded in Q3 2017.
- In the past 5 years, Syndax Pharmaceuticals' Interest & Investment Income registered a high of $462000.0 during Q4 2017, and its lowest value of -$524000.0 during Q4 2015.
- Its 3-year average for Interest & Investment Income is $118454.5, with a median of $268000.0 in 2016.
- Its Interest & Investment Income has fluctuated over the past 5 years, first surged by 21703.06% in 2016, then surged by 507.25% in 2017.
- Over the past 3 years, Syndax Pharmaceuticals' Interest & Investment Income (Quarter) stood at -$524000.0 in 2015, then surged by 151.15% to $268000.0 in 2016, then surged by 72.39% to $462000.0 in 2017.
- Its Interest & Investment Income was $462000.0 in Q4 2017, compared to $411000.0 in Q3 2017 and $290000.0 in Q2 2017.